CORNING INCORPORATED for CORNING INCORPORATED
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2017 | $370,000 | Replaced |
| 1st Quarter - Amendment | Mar 20, 2019 | $380,000 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
FY17/18 EPA Appropriations (no Appropriations Bills introduced yet).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J REGAN | — |
Transportation TRA
PL 114-183, PIPES Act of 2016 - Section 3, Regulatory Updates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STANLEY G FENDLEY | — |
Taxation/Internal Revenue Code TAX
Tax reform proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STANLEY G FENDLEY | — |
Copyright/Patent/Trademark CPT
Impact of 28 USC 1782 on IP protections.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STANLEY G FENDLEY | — |
Telecommunications TEC
Broadband components of infrastructure (no legislation introduced yet).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J REGAN | — |
Budget/Appropriations BUD
Implementation of H.R. 34 (PL 114-255), 21st Century Cures Act, NIH funding section (no Appropriations Bills introduced yet); Lobbying issues: FY 17/18 NIH Appropriations; FY 17/18 FDA Appropriations; and FY 17/18 EPA Appropriations (no Appropriations Bills introduced yet).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J REGAN | — |
Trade (domestic/foreign) TRD
Tariff and non-tariff barriers on optical fiber; WTO; Environmental Goods Agreement (EGA); APEC; China market access; Trade secrets protection; India Trade; Investment; Taiwan Trade, and NAFTA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA WAGGONER | — |
Health Issues HCR
Implementation of H.R. 34 (PL 114-255), 21st Century Cures Act, NIH funding section (no Appropriations Bills introduced yet); FDA issues (no legislation introduced yet).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J REGAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.